These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20333774)

  • 1. Malpositioned PFO device repair after the fact. Percutaneously? Really?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):782-3. PubMed ID: 20333774
    [No Abstract]   [Full Text] [Related]  

  • 2. Snares for embolized septal occluders: retrieval of tangled, twisted, and mangled devices in structural heart intervention.
    Feldman T
    Catheter Cardiovasc Interv; 2011 May; 77(6):901-2. PubMed ID: 21520388
    [No Abstract]   [Full Text] [Related]  

  • 3. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 4. Closing one hole leads to another: delayed aortic perforation following closure of a patent foramen ovale.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):135-6. PubMed ID: 20578219
    [No Abstract]   [Full Text] [Related]  

  • 5. Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?
    DiBardino DJ; Mayer JE
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):222-3. PubMed ID: 21683840
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous retrieval of the locked helex septal occluder.
    Poommipanit P; Levi D; Shenoda M; Tobis J
    Catheter Cardiovasc Interv; 2011 May; 77(6):892-900. PubMed ID: 20853357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device closure of patent foramen ovale--do similar devices achieve similar results?
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):715. PubMed ID: 21433274
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment.
    Gori T; Schräder R; Genth-Zotz S
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):778-81. PubMed ID: 20091815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
    Aaron S; Mainzer G; Lorber A
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):678-80. PubMed ID: 21805618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
    Meier B
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):652. PubMed ID: 19780059
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent foramen ovale and migraine headaches: the saga continues.
    Tobis J
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
    [No Abstract]   [Full Text] [Related]  

  • 13. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D; Fabbiocchi F; Montorsi P; Galli S; Teruzzi G; Grancini L; Gatto P; Bartorelli AL
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):570-4. PubMed ID: 21351231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation.
    Narayan V; Puri P; Mehra AO
    J Invasive Cardiol; 2008 Aug; 20(8):E247-9. PubMed ID: 18688073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 18. Closure of persistent foramen ovale with the BioSTAR biodegradable PFO closure device: feasibility and long-term outcome.
    Karagianni A; Abrahamsson P; Furenäs E; Eriksson P; Dellborg M
    Scand Cardiovasc J; 2011 Oct; 45(5):267-72. PubMed ID: 21728789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late patent foramen ovale occluder device embolization.
    Gaspardone A; Giardina A; Gioffrè G; Iamele M; Borioni R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):282-4. PubMed ID: 21386687
    [No Abstract]   [Full Text] [Related]  

  • 20. Late thrombus formation on the Helex septal occluder after double-lung transplant.
    Zaidi AN; Cheatham JP; Galantowicz M; Astor T; Kovalchin JP
    J Heart Lung Transplant; 2010 Jul; 29(7):814-6. PubMed ID: 20382035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.